These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33478353)

  • 1. Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis.
    Lin F; Wang H; Ding W; Chen G; Zhang Z
    Vascular; 2021 Dec; 29(6):883-896. PubMed ID: 33478353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 4. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials.
    Diamantopoulos A; Katsanos K
    J Cardiovasc Surg (Torino); 2014 Oct; 55(5):655-65. PubMed ID: 25008063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
    Katsanos K; Spiliopoulos S; Paraskevopoulos I; Diamantopoulos A; Karnabatidis D
    J Endovasc Ther; 2016 Apr; 23(2):356-70. PubMed ID: 26823485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials.
    Anantha-Narayanan M; Shah SM; Jelani QU; Garcia S; Ionescu C; Regan C; Mena-Hurtado C
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):139-148. PubMed ID: 30838719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C; Tang W; Ren T; Chen Q; Lu R; Gao Y
    J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
    Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Atherectomy to Balloon Angioplasty and Stenting for Isolated Femoropopliteal Revascularization.
    Bai H; Fereydooni A; Zhuo H; Zhang Y; Tonnessen BH; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2020 Nov; 69():261-273. PubMed ID: 32512112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The Chronic Total Occlusion Cohort in the IN.PACT Global Study.
    Tepe G; Micari A; Keirse K; Zeller T; Scheinert D; Li P; Schmahl R; Jaff MR;
    JACC Cardiovasc Interv; 2019 Mar; 12(5):484-493. PubMed ID: 30846089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Adjunctive Drug-Coated Versus Uncoated Balloon after Atherectomy in Femoropopliteal Artery Disease.
    Lee YJ; Ko YG; Ahn CM; Hong SJ; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    Ann Vasc Surg; 2020 Oct; 68():391-399. PubMed ID: 32339691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robustness of Longitudinal Safety and Efficacy After Paclitaxel-Based Endovascular Therapy for Treatment of Femoro-Popliteal Artery Occlusive Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    D'Oria M; Mastrorilli D; Secemsky E; Behrendt CA; Veraldi G; DeMartino R; Mani K; Budtz-Lilly J; Scali S; Saab F; Calvagna C; Mezzetto L; Ruaro B; Lepidi S
    Ann Vasc Surg; 2024 Apr; 101():164-178. PubMed ID: 38154491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directional Atherectomy with Antirestenotic Therapy for Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.
    Zhen Y; Chang Z; Wang C; Liu Z; Zheng J
    J Vasc Interv Radiol; 2019 Oct; 30(10):1586-1592. PubMed ID: 31471198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.